H.R. 6839 — Introduced in House

I 117th CONGRESS 2d Session H. R. 6839 IN THE HOUSE OF REPRESENTATIVES February 25, 2022 Mr. Hill (for himself, Mr. Mann, and Mr. Comer) introduced the following bill; which was referred to the Committee on Oversight and Reform A BILL To prohibit agencies of the Federal Government from evaluating bids and proposals on the basis of information related to noncompliance with a Federal contractor COVID–19 vaccine mandate, and for other purposes. 1. Short title This Act may be cited as the Protecting the Future of America’s Federal Contractors Act. 2. Prohibition on evaluating bids and proposals on basis of information related to noncompliance with Federal contractor COVID–19 vaccine mandate (a) Prohibition With respect to a bid or proposal for a contract with an agency of the Federal Government for the procurement of a good or service, the head of such agency may not, on the basis of COVID–19 Federal contractor vaccine mandate noncompliance information— (1) in evaluating the past performance of the offeror of such bid or proposal, unfavorably evaluate the offeror; or (2) exclude the offeror from being awarded the contract. (b) Definitions In this section: (1) COVID–19 Federal contractor vaccine mandate noncompliance information The term COVID–19 Federal contractor vaccine mandate noncompliance information means, with respect to the offeror, or any subcontractor disclosed by the offeror in the bid or proposal, information relating to compliance with a COVID–19 Federal contractor vaccine mandate, including information related to the termination of a contract with the Federal Government, or subcontract thereof at any tier, for the failure to comply with a Federal contractor vaccine mandate. (2) Federal contractor COVID–19 vaccine mandate The term Federal contractor COVID–19 vaccine mandate means a requirement by the Federal Government for any employee of a contractor of the Federal Government, or employee of a subcontractor thereof at any tier, to receive vaccination against infection by the SARS–CoV–2 virus.